Harrow Health, Inc.HROWNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank57
3Y CAGR-26.4%
5Y CAGR-14.1%
Year-over-Year Change
Enterprise value to EBITDA ratio
3Y CAGR
-26.4%/yr
Annual compound
5Y CAGR
-14.1%/yr
Recent deceleration
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 35.31 | -43.3% |
| 2024 | 62.26 | +54.4% |
| 2023 | 40.32 | -54.5% |
| 2022 | 88.69 | +69.6% |
| 2021 | 52.31 | -30.5% |
| 2020 | 75.30 | -32.6% |
| 2019 | 111.77 | +382.9% |
| 2018 | -39.51 | -807.7% |
| 2017 | -4.35 | -68.2% |
| 2016 | -2.59 | - |